Lansforsakringar Fondforvaltning’s Pfizer PFE Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$49.2M	Sell	2,042,458 -1,116,367	-35%	-$29.2M	0.22%	82
2026 Q1	$88.7M	Buy	3,158,825 +103,600	+3%	+$2.76M	0.46%	36
2025 Q4	$76.1M	Buy	3,055,225 +162,117	+6%	+$4.09M	0.38%	44
2025 Q3	$73.7M	Sell	2,893,108 -426,228	-13%	-$10.5M	0.38%	41
2025 Q2	$80.5M	Sell	3,319,336 -111,097	-3%	-$2.59M	0.46%	37
2025 Q1	$86.9M	Sell	3,430,433 -66,558	-2%	-$1.74M	0.53%	30
2024 Q4	$92.8M	Buy	+3,496,991	New	+$94.9M	0.52%	30

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Lansforsakringar Fondforvaltning's PFE Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning reduced its Pfizer (PFE) stake by 35% in Q2 2026, selling an estimated $29.2M and leaving 2,042,458 shares worth $49.2M. The position accounts for 0.22% of the portfolio, ranked #82.

Lansforsakringar Fondforvaltning first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $92.8M in Q4 2024. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Lansforsakringar Fondforvaltning held 2,042,458 shares of Pfizer worth $49.2M as of Q2 2026.
Lansforsakringar Fondforvaltning sold 1,116,367 Pfizer shares in Q2 2026, an estimated $29.2M.
Pfizer made up 0.22% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #82 holding.
Lansforsakringar Fondforvaltning first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Lansforsakringar Fondforvaltning's Pfizer position peaked at $92.8M in Q4 2024.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.